40th Annual New York Cardiovascular
Symposium - Major Topics in Cardiology Today
Co-sponsored
by:
Program Director: Valentin Fuster, MD,
PhD, FACC
Dec.
7–9, 2007
Hilton New York
New York, NY
PROGRAM PRESENTATIONS
Please note that pdfs are not listed for all program presentations as some faculty were unable to provide their full slide presentations to ACCF. Please refer to your printed syllabus for the key slides and/or abstracts that were released at the program.
NOTE: Click
here for Audio from the New York Cardiovascular Symposium.
FRIDAY, DECEMBER 7
7:45 a.m. Atherothrombosis: Cellular and Molecular Bases Protecting Vascular Health
Dr. Fuster
8:10 a.m. IVUS: The Therapies for Atherosclerosis Victories and Failures
Dr. Nissen
8:35 a.m. STEMI: Community Centers- Is Mechanical Taking over Fibrinolytic Management?
Dr. Antman
9:00 a.m. Two Challenges in Management - From Acute Shock to Asymptomatic Post MI
Dr. Hochman
9:25 a.m. NSTE-ACS: Stratification for Selection of Patients - New Aspects in Pharmacological Management
Dr. Cannon
9:50 a.m. NSTE-ACS: Stratification for Selection of Patients - New Aspects in Interventional Management
Dr. Grines
10:35 a.m. COURAGE and Stable Angina: A Case for Medical Management - Is the Interventional Approach Biased by ACS Trials?
Dr. Boden
11:00 a.m. Aspirin/Clopidogrel Resistance: An Emerging Clinical Entity in 2007? - Or, Do We Not Know What We are Talking About?
Dr. Bhatt
1:15 p.m. From Risk Factors to Bioimaging Markers
Dr. Fuster
1:40 p.m. From Risk Factors to Genetics and Serum Markers,
Relevance of Genetics and Genomics Abstract,
Improving Coronary Heart Disease Risk Assessment in Asymptomatic People
Dr. O’Donnell
2:05 p.m. Carotid, Aortic and Peripheral Vascular Disease: Powerful Markers of Coronary Disease and Prognosis
Dr. Olin
3:15 p.m. Targeting HDL: What is the Bottom Line?
Dr. Rader
3:40 p.m. Recent Trials in Hypertension: Is There Anything Really New?
Dr. Frohlich
4:05 p.m. Diabetes: Are the Cardiologists Ready to Manage? If Not, Who is the Manager?
Dr. McGuire
4:30 p.m. PAUL DUDLEY WHITE LECTURE - Antithrombotics: Chronic Disease and Stenting - New Agents and Evolving Approaches
Dr. Cannon
SATURAY, DECEMBER 8
7:30 a.m. Cellular, Biochemical and Humoral Pathways -Helpful for the Clinician or for the Researcher?
Dr. A. Feldman
7:50 a.m. Hemodynamic Patterns: Should We Always Measure for Initiation and Tailoring Therapy?
Dr. Mancini
8:10 a.m. How to Prevent Hospitalization —Home Quality Management
Dr. Yancy
8:30 a.m. LVAD as Destination Therapy: State of the Art and Predicting the Future
Dr. Young
9:40 a.m. BNP: Essential in Monitoring Myocardial Dysfunction? Real Value and Aspects of Caution
Dr. Young
10:00 a.m. MRI: Essential in Evaluating Myocardial Dysfunction? Evolving “Guidance” in Diagnosis, Prognosis and Therapy
Dr. Garcia
10:20 a.m. ICD Therapy/Biventricular Pacers: New Stratification in 2007
Dr. Oral
10:40 a.m. Surgical Remodeling: Coming Back for Specific Entities? LV Failure and Mitral Valve Regurgitation
Dr. Pinney
11:00 a.m. Diastolic Dysfunction: Can We Alter It?
Dr. Mancini
11:20 a.m. Hypertrophy Cardiomyopathy: Challenging Evolving Approaches - Management of Family, Muscle and Rhythm
The Case for Surgery in Obstructive Hypertrophic Cardiomyopathy
Surgical Myectomy
Dr. Maron
11:40 a.m. Restrictive Cardiomyopathy: Is Amyloid Heart Treatable? Variable Prognosis According to Type
Dr. Falk
1:30 p.m. Challenging Issues
Dr. Fuster
1:50 p.m. Antithrombotics for Stroke Prevention: What Guidelines to Follow and New Evolving Approaches
Dr. Halperin
2:10 p.m. Rate vs. Rhythm Control:Listen Carefully to the Patient, Project at His/Her Future, Then the Algorithms
Dr. Conti
2:30 p.m. Catheter Ablation as Compared to the Surgical Cox Maze: Myths and Realities
Dr. Oral
3:40 p.m. Timing of Indications for Valvular Heart Surgery: Should We Advance the Clock?
Dr. Bonow
4:00 p.m. Approaches to the Dilated Thoracic Aorta: Should We Also Advance the Clock?
Dr. Griepp
4:20 p.m. Quality Improvement in Valvular Heart Disease: Where Do We Go From Here?
Dr. Adams
4:40 p.m. The Ross Procedure — State of the Art and Predicting the Future
Dr. Stelzer
SUNDAY, DECEMBER 9
7:30 a.m. Genetics and Personalized Medicine: A Nice Concept Rather Than a Reality?
Prospects for Personalized Cardiovascular Medicine: The Impact of Genomics
Gene Expression Analysis of Cardiovascular Diseases
Dr. Ginsburg
7:50 a.m. Genetic Variants in CAD: A Short-Term Deception, But a Long-Term Hope?
Genetic Approaches to Coronary Heart Disease
Dr. Spertus
8:10 a.m. Myocardial Regeneration: Returning to Molecular and Cellular Basics?
Dr. Losordo
8:30 a.m. Gene Therapy for Myocardial Dysfunction: Hope Coming Back!
Dr. Hajjar
8:50 a.m. Molecular MRI/CT: Ready for Humans?
Dr. Fayad
9:30 a.m. Novelties on Percutaneous Aortic Valve Replacement
Dr. Moses
9:50 a.m. Novelties on Percutaneous Mitral Valve Repair Abstract
Dr. T. Feldman
10:10 a.m. Novelties on Coronary Interventional Devices
Dr. Sharma
10:50 a.m. The Elderly and Society: A Challenging Future in What Respect?
Dr. Fuster
11:10 a.m. HENRY I. RUSSEK LECTURE - The Elderly and Cardiovascular Disease: A Challenging Future in What Respect?
Dr. Califf |
